Skip to content

Prostective evaluation study for establishing treatment of pediatric fuctional gstrointestinal disorder and orthostatic disregulation patients

Prostective evaluation study for establishing treatment of pediatric fuctional gstrointestinal disorder and orthostatic disregulation patients - Study for establishing treatment in pediatric fuctional gastrointestinal disorder patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000017786
Enrollment
40
Registered
2015-07-01
Start date
2015-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pediatric functional gastrointestinal disorders Orthostatic dysregulation

Interventions

1.Hydrogen Breath Tests At the start of the test, fasting breath hydrogen is estimated 3 to 4 times. Subsequently, the subject ingests a fixed amount of gulucose(1g/kg, max100g). 2.13C-acetate Bre

Sponsors

Juntendo University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: <Functional gastrointestinal disorders> Must include all of the following. 1.At obtaining informed consent, => 6 y.o and < 20 y.o 2.Based on ROMA 3 criteria, diagnosed as fuctional gastrointestinal disorders 3.It is possible to cease treatment affecting gastrointestinal function, autonomic nerve system and psycosocial factors 4.No evidence of respiratory disease and liver disease 5.No history of gastrointestinal surgery 6.Not suffering from acute disorders such as upper respiratory inflammatory and acute gastroenteritis 7.After receiving a sufficient explanation, obtained from patients or legal representative informed consent <Orthostatic dysregulation patients> Must include all of the following. 1.At obtaining informed consent, => 6 y.o and < 20 y.o 2.Must fulfill criteria by standing test 3.No evidence of structural disease 4.It is possible to cease treatment 5.Not suffering from acute disorders such as upper respiratory inflammatory and acute gastroenteritis 6.After receiving a sufficient explanation, obtained from patients or legal representative informed consent

Exclusion criteria

Exclusion criteria: Include one or more of the following. 1.At informed consent, < 6 y.o and => 20y.o 2.It is impossible to cease treatment 3.History of gastrointestinal surgery 4.It is impossible to communicate 5.Determined to inappreciate by investigator

Design outcomes

Primary

MeasureTime frame
To evaluate emptying and peristalsis of stomach To evaluate small intestinal bacterial overgrowth

Secondary

MeasureTime frame
autonomic nervous function, cognitive assessment, psycological assessment, Quality of life assessment, stress assessment

Countries

Japan

Contacts

Public ContactKenji Hosoi

Juntendo University Pediatrics and Adolescent Medicine

khosoi@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026